These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11356105)

  • 1. Ether phospholipid-AZT conjugates possessing anti-HIV and antitumor cell activity. Synthesis, conformational analysis, and study of their thermal effects on membrane bilayers.
    Mavromoustakos T; Calogeropoulou T; Koufaki M; Kolocouris A; Daliani I; Demetzos C; Meng Z; Makriyannis A; Balzarini J; De Clercq E
    J Med Chem; 2001 May; 44(11):1702-9. PubMed ID: 11356105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antiretroviral evaluation of new alkoxy and aryloxy phosphate derivatives of 3'-azido-3'-deoxythymidine.
    Tsotinis A; Calogeropoulou T; Koufaki M; Souli C; Balzarini J; De Clercq E; Makriyannis A
    J Med Chem; 1996 Aug; 39(17):3418-22. PubMed ID: 8765527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular metabolism in lymphocytes of a novel thioether-phospholipid-AZT conjugate with anti-HIV-1 activity.
    Kucera GL; Goff CL; Iyer N; Morris-Natschke S; Ishaq KS; Wyrick SD; Fleming RA; Kucera LS
    Antiviral Res; 2001 May; 50(2):129-37. PubMed ID: 11369433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of novel ether lipid nucleoside conjugates for anti-HIV-1 activity.
    Piantadosi C; Marasco CJ; Morris-Natschke SL; Meyer KL; Gumus F; Surles JR; Ishaq KS; Kucera LS; Iyer N; Wallen CA
    J Med Chem; 1991 Apr; 34(4):1408-14. PubMed ID: 1901911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, anti-HIV activity and stability studies of 3'-azido-2',3'-dideoxythymidine 5'-fluorophosphate.
    Egron D; Arzumanov AA; Dyatkina NB; Krayevsky A; Imbach JL; Aubertin AM; Gosselin G; Périgaud C
    Nucleosides Nucleotides; 1999; 18(4-5):983-4. PubMed ID: 10432725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SATE (aryl) phosphotriester series. I. Synthesis and biological evaluation.
    Peyrottes S; Gosselin G; Aubertin AM; Périgaud C
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):903-5. PubMed ID: 14565307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AZT and AZT-monophosphate prodrugs incorporating HIV-protease substrate fragment: synthesis and evaluation as specific drug delivery systems.
    Liotard JF; Mehiri M; Di Giorgio A; Boggetto N; Reboud-Ravaux M; Aubertin AM; Condom R; Patino N
    Antivir Chem Chemother; 2006; 17(4):193-213. PubMed ID: 17066898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AZT-5'-(p-bromophenyl methoxyalaninyl phosphate) as a potent and non-toxic anti-human immunodeficiency virus agent.
    Jan ST; Zhu Z; Tai HL; Shih MJ; Venkatachalam TK; Uckun FM
    Antivir Chem Chemother; 1999 Jan; 10(1):47-52. PubMed ID: 10079879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and in vitro activity of long-chain 5'-O-[(alkoxycarbonyl)phosphinyl]-3'-azido-3'-deoxythymidines against wild-type and AZT- and foscarnet-resistant strains of HIV-1.
    Rosowsky A; Fu H; Pai N; Mellors J; Richman DD; Hostetler KY
    J Med Chem; 1997 Aug; 40(16):2482-90. PubMed ID: 9258355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of "AZT-HEPT", "AZT-pyridinone", and "ddC-HEPT" conjugates as inhibitors of HIV reverse transcriptase.
    Pontikis R; Dollé V; Guillaumel J; Dechaux E; Note R; Nguyen CH; Legraverend M; Bisagni E; Aubertin AM; Grierson DS; Monneret C
    J Med Chem; 2000 May; 43(10):1927-39. PubMed ID: 10821705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and anti-retroviral activity of O,O'-bis(3'-azido-2',3'-dideoxythymidin-5'-yl) phosphoramidate derivatives.
    Kers I; Stawiński J; Girardet JL; Imbach JL; Périgaud C; Gosselin G; Aubertin AM
    Nucleosides Nucleotides; 1999 Oct; 18(10):2317-25. PubMed ID: 10616733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino acid phosphoramidate monoesters of 3'-azido-3'-deoxythymidine: relationship between antiviral potency and intracellular metabolism.
    Chang S; Griesgraber GW; Southern PJ; Wagner CR
    J Med Chem; 2001 Jan; 44(2):223-31. PubMed ID: 11170632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new DNA building block, 4'-selenothymidine: synthesis and modification to 4'-seleno-AZT as a potential anti-HIV agent.
    Alexander V; Choi WJ; Chun J; Kim HO; Jeon JH; Tosh DK; Lee HW; Chandra G; Choi J; Jeong LS
    Org Lett; 2010 May; 12(10):2242-5. PubMed ID: 20405850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxicity of 3'-azido-3'-deoxythymidine correlates with 3'-azidothymidine-5'-monophosphate (AZTMP) levels, whereas anti-human immunodeficiency virus (HIV) activity correlates with 3'-azidothymidine-5'-triphosphate (AZTTP) levels in cultured CEM T-lymphoblastoid cells.
    Törnevik Y; Ullman B; Balzarini J; Wahren B; Eriksson S
    Biochem Pharmacol; 1995 Mar; 49(6):829-37. PubMed ID: 7702641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New 3'-azido-3'-deoxythymidin-5'-yl O-(omega-hydroxyalkyl) carbonate prodrugs: synthesis and anti-HIV evaluation.
    Vlieghe P; Bihel F; Clerc T; Pannecouque C; Witvrouw M; De Clercq E; Salles JP; Chermann JC; Kraus JL
    J Med Chem; 2001 Mar; 44(5):777-86. PubMed ID: 11262088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro evaluation and characterization of newly designed alkylamidophospholipid analogues as anti-human immunodeficiency virus type 1 agents.
    Kucera LS; Iyer N; Morris-Natschke SL; Chen SY; Gumus F; Ishaq K; Herrmann DB
    Antivir Chem Chemother; 1998 Mar; 9(2):157-65. PubMed ID: 9875387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-HIV pronucleotides: decomposition pathways and correlation with biological activities.
    Egron D; Lefebvre I; Périgaud C; Beltran T; Pompon A; Gosselin G; Aubertin AM; Imbach JL
    Bioorg Med Chem Lett; 1998 May; 8(9):1045-50. PubMed ID: 9871705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral activity and cytotoxicity of novel zidovudine (AZT) derivatives and the relation to their chemical structure.
    Turk G; Moroni G; Pampuro S; Briñón MC; Salomón H
    Int J Antimicrob Agents; 2002 Oct; 20(4):282-8. PubMed ID: 12385685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New lipophilic derivatives of AZT and d4T 5'-phosphonates.
    Shirokova EA; Jasko MV; Khandazhinskaya AL; Yanvarev DV; Skoblov YS; Pronayeva TR; Fedyuk NV; Pokrovsky AG; Kukhanova MK
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):981-5. PubMed ID: 14565326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aryl phosphate derivatives of AZT retain activity against HIV1 in cell lines which are resistant to the action of AZT.
    McGuigan C; Pathirana RN; Mahmood N; Devine KG; Hay AJ
    Antiviral Res; 1992 Apr; 17(4):311-21. PubMed ID: 1642482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.